Shortcuts

Jonathan J. Mazelsky

President and Chief Executive Officer, IDEXX Laboratories, Inc.

Director

Age: 64

Director since:
October 2019

Committees:
None

Other current public company director service:

  • Dentsply Sirona Inc. (since May 2023)

Experience

IDEXX

  • President and CEO (since October 2019)
  • Interim President and CEO (June 2019 – October 2019)
  • Executive Vice President (August 2012 – June 2019)


Philips Healthcare, a subsidiary of Royal Philips Electronics (now named Royal Philips)

  • Senior Vice President and General Manager, Computed Tomography, Nuclear Medicine and Radiation Therapy Planning (2010 – 2012)
  • Various roles of increasing responsibility (2001 – 2010)


Agilent Technologies (acquired by Royal Philips Electronics in 2001)

  • Executive in Charge, Agilent Healthcare Solutions Group divestiture (2000 – 2002)
  • General Manager, Medical Consumables Business Unit (1997 – 2000)


Hewlett Packard

  • Various roles in finance, marketing and business planning (1988 – 1996)

Qualifications

  • Executive Leadership: Extensive leadership and management experience gained during his time in various roles at IDEXX, including as President and CEO during which time he has prioritized innovation,  built expanded commercial capabilities and scaled our warehouse, distribution and manufacturing capabilities to support continued growth, and as Executive Vice President, where he was responsible for the North American Companion Animal Group Commercial Organization and key elements of the innovation portfolio, including IDEXX VetLab in-house diagnostics, Diagnostic Imaging, Veterinary Software and Services, Rapid Assay and Telemedicine lines of business.
  • Corporate Strategy: Deep experience developing and implementing strategies for continued long-term sustainable growth at IDEXX, including transforming our go-to-market strategy in North America in 2014, significant international commercial expansions, investments in innovation and an emphasis on delivering a differentiated customer experience.
  • Innovation and R&D: Substantial experience leading organizations to create innovative, integrated healthcare solutions that improve the standard of care, including at Philips Healthcare and IDEXX; as President and CEO of IDEXX, he has prioritized investment in (and focus on) intelligent innovation, resulting in the introduction of multiple customer-centric products and services that will advance pet healthcare, including IDEXX Cancer Dx (a first-of-its-kind diagnostic panel that detects canine lymphoma), IDEXX inVue Dx Cellular Analyzer (a slide-free instrument that assesses cells in their natural state) and Vello (a pet-owner engagement software solution).    
  • Mr. Mazelsky also brings significant corporate governance, financial acumen, human capital management, international business, digital, corporate finance (including mergers and acquisitions), operations, sustainability and risk oversight skills and experience to the Board. 

Education

  • BA, Mathematics, University of Rochester
  • MBA, University of Chicago Booth School of Business